Disc Medicine, Inc.
IRON
$92.38
$2.662.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 78.65% | 68.57% | 51.88% | 51.18% | 54.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.03% | 52.06% | 41.80% | 42.35% | 63.39% |
| Operating Income | -63.03% | -52.06% | -41.80% | -42.35% | -63.39% |
| Income Before Tax | -74.94% | -59.46% | -44.10% | -42.80% | -61.29% |
| Income Tax Expenses | 112.80% | 294.02% | 479.01% | 258.59% | 214.93% |
| Earnings from Continuing Operations | -75.02% | -59.76% | -44.54% | -43.08% | -61.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.02% | -59.76% | -44.54% | -43.08% | -61.45% |
| EBIT | -63.03% | -52.06% | -41.80% | -42.35% | -63.39% |
| EBITDA | -63.10% | -52.20% | -41.80% | -42.34% | -63.38% |
| EPS Basic | -34.97% | -22.19% | -16.22% | -14.18% | 63.90% |
| Normalized Basic EPS | -32.82% | -19.92% | -16.16% | -14.26% | 63.16% |
| EPS Diluted | -34.97% | -22.19% | -16.22% | -14.18% | 63.90% |
| Normalized Diluted EPS | -32.82% | -19.92% | -16.16% | -14.26% | 63.16% |
| Average Basic Shares Outstanding | 27.36% | 29.28% | 25.08% | 23.75% | 58.65% |
| Average Diluted Shares Outstanding | 27.36% | 29.28% | 25.08% | 23.75% | 58.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |